IRIS
DI BENEDETTO, PAOLA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.307
EU - Europa 1.394
AS - Asia 569
OC - Oceania 5
Continente sconosciuto - Info sul continente non disponibili 4
SA - Sud America 2
AF - Africa 1
Totale 4.282
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.299
IE - Irlanda 533
CN - Cina 323
SE - Svezia 218
TR - Turchia 189
IT - Italia 168
UA - Ucraina 127
DE - Germania 126
GB - Regno Unito 90
FR - Francia 49
FI - Finlandia 43
VN - Vietnam 26
BE - Belgio 24
IN - India 21
CA - Canada 6
AU - Australia 4
ES - Italia 3
EU - Europa 3
MK - Macedonia 3
BR - Brasile 2
CH - Svizzera 2
HK - Hong Kong 2
SG - Singapore 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AT - Austria 1
BG - Bulgaria 1
CI - Costa d'Avorio 1
DK - Danimarca 1
GE - Georgia 1
ID - Indonesia 1
IR - Iran 1
KR - Corea 1
LB - Libano 1
LU - Lussemburgo 1
MD - Moldavia 1
MX - Messico 1
NL - Olanda 1
NZ - Nuova Zelanda 1
PH - Filippine 1
PR - Porto Rico 1
RO - Romania 1
RU - Federazione Russa 1
Totale 4.282
Salva come PNG Salva come JPEG
Città #
Chandler 603
Dublin 533
Jacksonville 530
Izmir 137
Ann Arbor 95
New York 88
L'aquila 82
Nanjing 80
Lawrence 75
Princeton 75
Boardman 68
Ashburn 67
Wilmington 63
Beijing 60
San Mateo 44
Dearborn 42
Woodbridge 35
Nanchang 31
Dong Ket 26
Milan 25
Brussels 20
Verona 18
Mountain View 16
Shenyang 16
Kunming 15
Seattle 14
Jiaxing 13
Des Moines 11
Hebei 11
Zhengzhou 11
L’Aquila 10
Changsha 9
Hefei 9
Ningbo 9
Pune 9
Tianjin 9
Grafing 8
Helsinki 8
Jinan 8
Norwalk 8
Houston 6
Shanghai 6
Bremen 5
Edinburgh 5
Hangzhou 5
Lanzhou 5
Fremont 4
Guangzhou 4
Leuven 4
Redwood City 4
Rome 4
Washington 4
Changchun 3
Naples 3
Stockholm 3
Taizhou 3
Brisbane 2
Chengdu 2
Frankfurt am Main 2
Jinhua 2
Madrid 2
Melbourne 2
Montreal 2
New Delhi 2
Paris 2
Skopje 2
Aquila 1
Arlington 1
Auburn Hills 1
Auckland 1
Bandung 1
Barcelona 1
Basel 1
Bournemouth 1
Brindisi 1
Casal di Principe 1
Cedar Knolls 1
Central 1
Central District 1
Chicago 1
Chisinau 1
Chongqing 1
Città di Castello 1
Copenhagen 1
Fairfield 1
Fuzhou 1
Gevgelija 1
Godalming 1
Harbin 1
Isernia 1
Kish 1
Los Angeles 1
Luxembourg 1
Manila 1
Miami 1
Mumbai 1
Navirai 1
Odesa 1
Orange 1
Ottawa 1
Totale 3.113
Salva come PNG Salva come JPEG
Nome #
Perivascular cells in diffuse cutaneous systemic sclerosis overexpress activated ADAM12 and are involved in myofibroblast transdifferentiation and development of fibrosis 109
Role of CD248 molecule as potential regulator of trans-differentiation toward myofibroblasts of perivascular stromal cells in systemic sclerosis patients 95
Advances in immunopathogenesis of macrophage activation syndrome during rheumatic inflammatory diseases: toward new therapeutic targets? 93
The CD68+/H-ferritin+ cells colonize the lymph nodes of the patients with adult onset Still's disease and are associated with increased extracellular level of H-ferritin in the same tissue: Correlation with disease severity and implication for pathogenesis 91
Adult-onset Still's disease: evaluation of prognostic tools and validation of the systemic score by analysis of 100 cases from three centers 87
The emerging role of IL-1 inhibition in patients affected by rheumatoid arthritis and diabetes 87
Monocytes from patients with rheumatoid arthritis and type 2 diabetes mellitus display an increased production of interleukin (IL)-1β via the nucleotide-binding domain and leucine-rich repeat containing family pyrin 3(NLRP3)-inflammasome activation: a possible implication for therapeutic decision in these patients. 87
Prognostic factors of adult onset Still’s disease: analysis of 100 cases in 3 tertiary referral centers 87
H-ferritin and CD68(+) /H-ferritin(+) monocytes/macrophages are increased in the skin of adult-onset Still's disease patients and correlate with the multi-visceral involvement of the disease 86
The role of extracellular matrix components in angiogenesis and fibrosis: Possible implication for Systemic Sclerosis. 85
Prognostic factors of macrophage activation syndrome, at the time of diagnosis, in adult patients affected by autoimmune disease: Analysis of 41 cases collected in 2 rheumatologic centers 85
Macitentan inhibits the transforming growth factor-β profibrotic action, blocking the signaling mediated by the ETR/TβRI complex in systemic sclerosis dermal fibroblasts 83
PTP4A1 promotes TGFβ signaling and fibrosis in systemic sclerosis 80
Biologic therapies and infections in the daily practice of three Italian rheumatologic units: a prospective, observational study 79
H-ferritin and proinflammatory cytokines are increased in the bone marrow of patients affected by macrophage activation syndrome 77
IL-1β at the crossroad between rheumatoid arthritis and type 2 diabetes: may we kill two birds with one stone? 74
Mesenchymal stromal cells and rheumatic diseases: new tools from pathogenesis to regenerative therapies. 74
EFFICACY AND SAFETY OF RITUXIMAB TREATMENT IN EARLY PRIMARY SJOGREN'S SYNDROME: A CLINICAL, HISTOLOGICAL AND MOLECULAR STUDY 72
Cardiovascular disease in primary sjögren’s syndrome 72
Increased cardiovascular events and subclinical atherosclerosis in rheumatoid arthritis patients: 1 year prospective single centre study 71
SENESCENT BONE MARROW DERIVED MESENCHYMAL STEM CELLS (MSC) ARE PRONE TO RECOVER DURING SSC 70
International consensus: What else can we do to improve diagnosis and therapeutic strategies in patients affected by autoimmune rheumatic diseases (rheumatoid arthritis, spondyloarthritides, systemic sclerosis, systemic lupus erythematosus, antiphospholipid syndrome and Sjogren's syndrome)?: The unmet needs and the clinical grey zone in autoimmune disease management. 70
SAT0489 Biologic Therapies and Infections in The Daily Practice: A Study on Historical Cohort from 3 Italian Rheumatologic Units 69
Impaired Endothelium-Mesenchymal Stem Cells Cross-talk in Systemic Sclerosis: a Link Between Vascular and Fibrotic Features. 68
Decreased Expression of Angiopoetin 1 on Perivascular Mesenchymal Stem Cells from Ssc Patients Induces an Anti Angiogenetic Effect, when Co-cultured with Endothelial Cells 67
The Role of IL-1β in the Bone Loss during Rheumatic Diseases 67
Mesenchymal stem cells (MSCs) from scleroderma patients (SSc) preserve their immunomodulatory properties although senescent and normally induce T regulatory cells (Tregs) with a functional phenotype: implications for cellular-based therapy. 67
Searching for a good model for systemic sclerosis: The molecular profile and vascular changes occurring in UCD-200 chickens strongly resemble the early phase of human systemic sclerosis 66
Increased level of H-ferritin and its imbalance with L-ferritin, in bone marrow and liver of patients with adult onset Still's disease, developing macrophage activation syndrome, correlate with the severity of the disease. 65
Interstitial lung disease in systemic sclerosis: current and future treatment. 64
The Endothelial-mesenchymal Transition in Systemic Sclerosis Is Induced by Endothelin-1 and Transforming Growth Factor-β and May Be Blocked by Macitentan, a Dual Endothelin-1 Receptor Antagonist. 62
Myofibroblast Cells Expression of CD248 May Contribute to Exacerbate Microvascular Damage during Systemic Sclerosis 60
Caveolin-1 orchestrates vascular endothelial growth factor (VEGF) signaling control of angiogenesis during systemic sclerosis (SSC) 59
Interleukin (IL)-17-producing pathogenic T lymphocytes co-express CD20 and are depleted by rituximab in primary Sjögren's syndrome: A pilot study 59
Pharmacological stress, rest perfusion and delayed enhancement cardiac magnetic resonance identifies a very early cardiac involvement in systemic sclerosis patients of recent onset 59
Cellular players in angiogenesis during the course of systemic sclerosis. 58
Mesenchymal stem cells transplantation in Systemic Sclerosis: comment on the article by ATJ Maria et al 57
Jejunoileal bypass as the main procedure in the onset of immune-related conditions: the model of BADAS. 56
Is minor salivary gland biopsy more than a diagnostic tool in primary Sjo¨gren׳s syndrome? Association between clinical, histopathological, and molecular features: A retrospective study 55
Efficacy and safety of rituximab treatment in early primary Sjögren's syndrome: a prospective, multi-center, follow-up study. 55
Different operators and histologic techniques in the assessment of germinal center-like structures in primary Sjögren's syndrome minor salivary glands 55
Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis 55
Adipocytokines in Rheumatoid Arthritis: The Hidden Link between Inflammation and Cardiometabolic Comorbidities 54
Blocking CD248 molecules in perivascular stromal cells of patients with systemic sclerosis strongly inhibits their differentiation toward myofibroblasts and proliferation: A new potential target for antifibrotic therapy 53
Aberrant cytokine expression and severity of the infiltrates are reverted by rituximab therapy in salivary glands of patients with sjogren’s syndrome 52
Senescent bone marrow mesenchymal stem cells (BM-MSCS) preserve their immune-regulatory effect on t cells during systemic sclerosis (SSC). 52
Persistence of focal lymphocytic sialadenitis in patients with primary Sjögren's syndrome treated with rituximab: a possible role for glandular BAFF 52
Scleroderma Mesenchymal Stem Cells display a different phenotype from healthy controls; implications for regenerative medicine. 51
Macrophages with regulatory functions, a possible new therapeutic perspective in autoimmune diseases 50
ASSESSING PRO-INFLAMMATORY PROPERTIES OF H-FERRITIN BY EX VIVO AND IN VITRO OBSERVATIONS 50
Pro-inflammatory properties of H-ferritin on human macrophages, ex vivo and in vitro observations 50
Mesenchymal stem cells of Systemic Sclerosis patients, derived from different sources, show a profibrotic microRNA profiling 49
IL-1 inhibition improves insulin resistance and adipokines in rheumatoid arthritis patients with comorbid type 2 diabetes: An observational study 49
CARDIAC MAGNETIC RESONANCE IMAGING WITH PHARMACOLOGICAL STRESS PERFUSION IN ASYMPTOMATIC PATIENTS WITH SYSTEMIC SCLEROSIS 48
 Epidermal growth factor-like domain 7 (EGFL7) in skin of systemic sclerosis 47
Epidermal Growth Factor Like-domain 7 and miR-126 are abnormally expressed in diffuse Systemic Sclerosis fibroblasts 47
Response to: ‘Correspondence on ‘Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence–radiological differences’ by Ruscitti et al’ by Chen et al 47
Adipose stromal vascular fraction and regenerative therapy in SSc: Response to the article by Magalon et al 46
The Vessels Contribute to Fibrosis in Systemic Sclerosis 46
Lung involvement in macrophage activation syndrome and severe COVID-19: results from a cross-sectional study to assess clinical, laboratory and artificial intelligence-radiological differences 45
VASCULAR SMOOTH MUSCLE CELLS (SMC) PROGENITORS: NEW PLAYERS IN SYSTEMIC SCLEROSIS (SSC) DEFECTIVE VESSEL REGENERATION. 44
Linking myofibroblast generation and microvascular alteration: The role of CD248 from pathogenesis to therapeutic target (Review) 42
Ferritin and C-reactive protein are predictive biomarkers of mortality and macrophage activation syndrome in adult onset Still's disease. Analysis of the multicentre Gruppo Italiano di Ricerca in Reumatologia Clinica e Sperimentale (GIRRCS) cohort 41
THU0582 Prognostic Factors of Macrophage Activation Syndrome in Adults: Analysis of 40 Cases in 2 Tertiary Referral Centers 40
Interleukin-32 in systemic sclerosis, a potential new biomarker for pulmonary arterial hypertension 40
Severe COVID-19, Another Piece in the Puzzle of the Hyperferritinemic Syndrome. An Immunomodulatory Perspective to Alleviate the Storm. 38
Blocking Jak/STAT signalling using tofacitinib inhibits angiogenesis in experimental arthritis 36
Association between clinical, histopathological and molecular features in primary Sjogren's Syndrome: a retrospective study 35
Design of noncompetitive interleukin-8 inhibitors acting on CXCR1 and CXCR2 35
Interstitial lung disease in systemic sclerosis: Pathophysiology and therapy 33
FRI0414 Evaluation of a novel multi-analyte assay for the detection of autoantibodies in the diagnosis of systemic sclerosis 31
Haematopoietic stem cell transplantation in systemic sclerosis: Challenges and perspectives 27
Potential of stem cells in the treatment of rheumatic disease 26
SAT0641 Performance and agreement of different operators and histological techniques for the assessment of germinal centres in minor salivary glands in primary sjÖgren’s syndrome 24
Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor 23
Phenotypical and functional characteristics of in vitro-expanded adipose-derived mesenchymal stromal cells from patients with systematic sclerosis 22
Totale 4.462
Salva come PNG Salva come JPEG
Categoria #
all - tutte 15.205
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 15.205
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/2019186 0 0 0 0 0 0 0 0 0 6 3 177
2019/2020639 94 6 66 13 12 100 94 18 69 31 4 132
2020/2021696 21 79 5 89 85 38 90 14 85 26 114 50
2021/2022457 25 16 97 38 11 10 4 24 33 38 37 124
2022/20231.580 113 115 29 199 108 166 2 95 675 12 46 20
2023/2024325 60 21 21 29 35 132 9 16 1 1 0 0
Totale 4.462